Angiotensin-Converting Enzyme Inhibitors [phsu]
receptor [aapp, rcpt]
Prevention [topp]
Type 2 Diabetes [dsyn]
Patients [podg]
Cardiovascular Diseases [dsyn]
Review, Systematic [inpr]
Meta-Analysis [inpr]
Purpose [ftcn]
Several [qnco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Type 2 Diabetes [dsyn]
Patients [podg]
Cardiovascular Diseases [dsyn]
Review, Systematic [inpr]
Meta-Analysis [inpr]
Performed [ftcn]
Efficacy [qlco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
PREVENT [phsu]
Type 2 Diabetes [dsyn]
Methods [inpr]
randomized controlled trials [inpr, resa]
PubMed [inpr]
Library [mnob, orgt]
Clinical Trials [resa]
GO [gngm]
Reviewer [qlco]
Assessed [acty]
search [inpr]
Extracted [topp]
Bias [idcn]
Meet [idcn]
Inclusion Criteria [qlco]
Subject [grup]
Patients [podg]
Received [qlco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Received [qlco]
Anti-Hypertensive Agents [phsu]
placebo [topp]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
reductions [npop]
Newly diagnosed diabetes [fndg]
Type 2 [clas]
Angiotensin-Converting Enzyme Inhibitors [phsu]
P NOS [aapp, imft]
Angiotensin Receptor Blockers [phsu]
P NOS [aapp, imft]
Pooled [cnce]
P NOS [aapp, imft]
Conclusions [idcn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Type 2 Diabetes [dsyn]
Patients [podg]
Hypertension [dsyn]
Metabolic syndrome [dsyn]
Pre-diabetes NOS [dsyn]
Phase [tmco]
Congestive heart failure [dsyn]
coronary heart disease [dsyn]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
Recommended [idcn]
Line [spco]
Anti-Hypertensive Agents [phsu]
Patients [podg]
Cardiovascular Diseases [dsyn]
